Anti-VEGF terapija u oftalmologiji (Serbian Wikipedia)
Analysis of information sources in references of the Wikipedia article "Anti-VEGF terapija u oftalmologiji" in Serbian language version.
refsWebsite
Global rank
Serbian rank
5th place
12th place
11th place
23rd place
6th place
5th place
1,389th place
438th place
8,869th place
8,510th place
1st place
1st place
aacrjournals.org
mct.aacrjournals.org
- Daekyu Sun; et al. (2008). „The proximal promoter region of the human vascular endothelial growth factor gene has a G-quadruplex structure that can be targeted by G-quadruplex–interactive agents”. Mol Cancer Ther April. 2008 (7): 880—889. PMC 2367258
. PMID 18413801. doi:10.1158/1535-7163.MCT-07-2119.
archive.org
- Meyer C.H., Mennel S., Schmidt J.C., Kroll P.: Acute retinal pigment epithelial tear following intravitreal bevaciyumab (Avastin) injection for occult choroidal neovascularization secondary to age-related macular degeneration. Meyer, C. H.; Mennel, S.; Schmidt, J. C.; Kroll, P. (2006). „Acute retinal pigment epithelial tear following intravitreal bevacizumab (Avastin) injection for occult choroidal neovascularisation secondary to age related macular degeneration”. Br J Ophthalmol. 90 (9): 1207—08. PMC 1857397 . PMID 16929069. doi:10.1136/bjo.2006.093732..
- Spitzer, M. S.; Wallenfels-Thilo, B.; Sierra, A.; Yoeruek, E.; Peters, S.; Henke-Fahle, S.; Bartz-Schmidt, K. U.; Szurman, P.; Tuebingen Bevacizumab Study Group (2006). „Antiproliferative and cytotoxic properties of bevacizumab on different ocular cells”. Br J Ophthalmol. 90 (10): 1316—21. PMC 1857456 . PMID 16723358. doi:10.1136/bjo.2006.095190..
- Brown, David M.; Michels, Mark; Kaiser, Peter K.; Heier, Jeffrey S.; Sy, Judy P.; Ianchulev, Tsontcho; Anchor Study, Group (2009). „Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study”. Ophthalmology. 116 (1): 57—65. PMID 19118696. doi:10.1016/j.ophtha.2008.10.018.
- Heier, J. S.; Brown, D. M.; Chong, V.; Korobelnik, J. F.; Kaiser, P. K.; Nguyen, Q. D.; Kirchhof, B.; Ho, A.; Ogura, Y.; Yancopoulos, G. D.; Stahl, N.; Vitti, R.; Berliner, A. J.; Soo, Y.; Anderesi, M.; Groetzbach, G.; Sommerauer, B.; Sandbrink, R.; Simader, C.; Schmidt-Erfurth, U.; VIEW 1 and VIEW 2 Study Groups (2012). „Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration”. Ophthalmology. 119 (12): 2537—2548. PMID 23084240. doi:10.1016/j.ophtha.2012.09.006.
- Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group; Martin, D. F.; Maguire, M. G.; Fine, S. L.; Ying, G. S.; Jaffe, G. J.; Grunwald, J. E.; Toth, C.; Redford, M.; Ferris Fl, 3rd (2012). „Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: Two-year results”. Ophthalmology. 119 (7): 1388—1398. PMC 3389193 . PMID 22555112. doi:10.1016/j.ophtha.2012.03.053..
cines.fr
imgt.cines.fr
- IGMT Link:http://imgt.cines.fr/3Dstructure-DB/cgi/details.cgi?pdbcode=1CZ8&Part=Chain Архивирано на сајту Wayback Machine (7. децембар 2008)
doi.org
doi.org
- Kaiser, Peter K. (2006). „Antivascular Endothelial Growth Factor Agents and Their Development: Therapeutic Implications in Ocular Diseases”. American Journal of Ophthalmology. 142 (4): 660—668.e1. ISSN 0002-9394. doi:10.1016/j.ajo.2006.05.061.
- Daekyu Sun; et al. (2005). „Facilitation of a structural transition in the polypurine/polypyrimidine tract within the proximal promoter region of the human VEGF gene by the presence of potassium and G-quadruplex-interactive agents”. Nucleic Acids Research. 33 (18): 6070—6080. PMC 1266068 . PMID 16239639. doi:10.1093/nar/gki917.
- Daekyu Sun; et al. (2008). „The proximal promoter region of the human vascular endothelial growth factor gene has a G-quadruplex structure that can be targeted by G-quadruplex–interactive agents”. Mol Cancer Ther April. 2008 (7): 880—889. PMC 2367258 . PMID 18413801. doi:10.1158/1535-7163.MCT-07-2119.
- Fernando, Himesh; Reszka, Anthony P.; Huppert, Julian; Ladame, Sylvain; Rankin, Sarah; Venkitaraman, Ashok R.; Neidle, Stephen; Balasubramanian, Shankar (2006-05-28). „A Conserved Quadruplex Motif Located in a Transcription Activation Site of the Human c-kit Oncogene”. Biochemistry. 45 (25): 7854—7860. ISSN 0006-2960. PMC 2195898 . PMID 16784237. doi:10.1021/bi0601510.
- Holmes K, Roberts OL, Thomas AM, Cross MJ (2007). „Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition.”. Cell Signal. 19 (10): 2003—2012. PMID 17658244. doi:10.1016/j.cellsig.2007.05.013.
- Stuttfeld, E.; Ballmer-Hofer K (2009). „Structure and function of VEGF receptors”. IUBMB Life. 61 (9): 915—22. PMID 19658168. S2CID 10190107. doi:10.1002/iub.234.
- Fujita, Nobuyuki; Imai, Jun-Ichi; Suzuki, Toru; Yamada, Masayuki; Ninomiya, Ken; Miyamoto, Kana; Iwasaki, Ryotaro; Morioka, Hideo; Matsumoto, Morio; Chiba, Kazuhiro; Watanabe, Shinya; Suda, Toshio; Toyama, Yoshiaki; Miyamoto, Takeshi (2008). „Vascular endothelial growth factor-A is a survival factor for nucleus pulposus cells in the intervertebral disc”. Biochemical and Biophysical Research Communications. 372 (2): 367—372. PMID 18492486. doi:10.1016/j.bbrc.2008.05.044.
- Gaudreault, J.; Fei, D.; Beyer, J. C.; Ryan, A.; Rangell, L.; Shiu, V.; Damico, L. A. (2007). „Pharmacokinetics and retinal distribution of ranibizumab, a humanized antibody fragment directed against VEGF-A, following intravitreal administration in rabbits”. Retina (Philadelphia, Pa.). 27 (9): 1260—6. PMID 18046235. S2CID 9336230. doi:10.1097/IAE.0b013e318134eecd.
- Gaudreault, J.; Fei, D.; Rusit, J.; Suboc, P.; Shiu, V. (2005). „Preclinical pharmacokinetics of Ranibizumab (RhuFabV2) after a single intravitreal administration”. Investigative Ophthalmology & Visual Science. 46 (2): 726—33. PMID 15671306. doi:10.1167/iovs.04-0601.
- Gaudreault, J.; Fei, D.; Beyer, J. C.; Ryan, A.; Rangell, L.; Shiu, V.; Damico, L. A. (2007). „Pharmacokinetics and retinal distribution of ranibizumab, a humanized antibody fragment directed against VEGF-A, following intravitreal administration in rabbits”. Retina (Philadelphia, Pa.). 27 (9): 1260—6. PMID 18046235. S2CID 9336230. doi:10.1097/IAE.0b013e318134eecd.
- Bakri, S. J.; Snyder, M. R.; Reid, J. M.; Pulido, J. S.; Ezzat, M. K.; Singh, R. J. (2007). „Pharmacokinetics of intravitreal ranibizumab (Lucentis)”. Ophthalmology. 114 (12): 2179—82. PMID 18054637. doi:10.1016/j.ophtha.2007.09.012.
- Kourlas, H.; Abrams, P. (2007). „Ranibizumab for the treatment of neovascular age-related macular degeneration: A review”. Clinical Therapeutics. 29 (9): 1850—61. PMID 18035187. doi:10.1016/j.clinthera.2007.09.008.
- Knox, Craig; Law, Vivian; Jewison, Timothy; Liu, Philip; Ly, Son; Frolkis, Alex; Pon, Allison; Banco, Kelly; Mak, Christine (2011). „DrugBank 3.0: a comprehensive resource for 'omics' research on drugs”. Nucleic Acids Research. 39 (Database issue): D1035—1041. ISSN 1362-4962. PMC 3013709 . PMID 21059682. doi:10.1093/nar/gkq1126.
- Wishart, David S.; Knox, Craig; Guo, An Chi; Cheng, Dean; Shrivastava, Savita; Tzur, Dan; Gautam, Bijaya; Hassanali, Murtaza (2008). „DrugBank: a knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Research. 36 (Database issue): D901—906. ISSN 1362-4962. PMC 2238889 . PMID 18048412. doi:10.1093/nar/gkm958.
- Gragoudas, E. S.; Adamis, A. P.; Cunningham Jr, E. T.; Feinsod, M.; Guyer, D. R.; VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group (2004). „Pegaptanib for neovascular age-related macular degeneration”. New England Journal of Medicine. 351 (27): 2805—16. PMID 15625332. S2CID 10050130. doi:10.1056/NEJMoa042760.
- Rosenfeld, Philip J.; Brown, David M.; Heier, Jeffrey S.; Boyer, David S.; Kaiser, Peter K.; Chung, Carol Y.; Kim, Robert Y. (2006-10-05). „Ranibizumab for Neovascular Age-Related Macular Degeneration”. New England Journal of Medicine. 355 (14): 1419—1431. ISSN 0028-4793. doi:10.1056/nejmoa054481.
- Brown, D. M.; Kaiser, P. K.; Michels, M.; Soubrane, G.; Heier, J. S.; Kim, R. Y.; Sy, J. P.; Schneider, S.; ANCHOR Study Group (2006). „Ranibizumab versus verteporfin for neovascular age-related macular degeneration”. New England Journal of Medicine. 355 (14): 1432—44. PMID 17021319. doi:10.1056/NEJMoa062655.
- Rosenfeld, Philip J. (2006). „Intravitreal Avastin: The Low Cost Alternative to Lucentis?”. American Journal of Ophthalmology. 142 (1): 141—143. ISSN 0002-9394. PMID 16815262. doi:10.1016/j.ajo.2006.03.036.
- Stone, E. M. (2006). „A very effective treatment for neovascular macular degeneration”. New England Journal of Medicine. 355 (14): 1493—95. PMID 17021326. doi:10.1056/NEJMe068191..
- Avery, Robert L.; Pieramici, Dante J.; Rabena, Melvin D.; Castellarin, Alessandro A.; Nasir, Ma’an A.; Giust, Matthew J. (2006). „Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration”. Ophthalmology. 113 (3): 363—372.e5. ISSN 0161-6420. PMID 16458968. doi:10.1016/j.ophtha.2005.11.019.
- Bashshur, Ziad F.; Bazarbachi, Ali; Schakal, Alexandre; Haddad, Zeina A.; El Haibi, Christelle P.; Noureddin, Baha’ N. (2006). „Intravitreal Bevacizumab for the Management of Choroidal Neovascularization in Age-related Macular Degeneration”. American Journal of Ophthalmology. 142 (1): 1—9. ISSN 0002-9394. PMID 16815245. doi:10.1016/j.ajo.2006.02.037.
- Meyer C.H., Mennel S., Schmidt J.C., Kroll P.: Acute retinal pigment epithelial tear following intravitreal bevaciyumab (Avastin) injection for occult choroidal neovascularization secondary to age-related macular degeneration. Meyer, C. H.; Mennel, S.; Schmidt, J. C.; Kroll, P. (2006). „Acute retinal pigment epithelial tear following intravitreal bevacizumab (Avastin) injection for occult choroidal neovascularisation secondary to age related macular degeneration”. Br J Ophthalmol. 90 (9): 1207—08. PMC 1857397 . PMID 16929069. doi:10.1136/bjo.2006.093732..
- Rudd, P; Siegler, M; Byyny, R L (1978). „Perioperative diabetic consultation”. Academic Medicine. 53 (7): 590—6. ISSN 1040-2446. doi:10.1097/00001888-197807000-00007.
- Luthra, S.; Narayanan, R.; Marques, L. E.; Chwa, M.; Kim, D. W.; Dong, J.; Seigel, G. M.; Neekhra, A.; Gramajo, A. L.; Brown, D. J.; Kenney, M. C.; Kuppermann, B. D. (2006). „Evaluation of in vitro effects of bevacizumab (Avastin) on retinal pigment epithelial, neurosensory retinal, and microvascular endothelial cells”. Retina. 26 (5): 512—18. PMID 16770256. S2CID 20956318. doi:10.1097/01.iae.0000222547.35820.52..
- Spitzer, M. S.; Wallenfels-Thilo, B.; Sierra, A.; Yoeruek, E.; Peters, S.; Henke-Fahle, S.; Bartz-Schmidt, K. U.; Szurman, P.; Tuebingen Bevacizumab Study Group (2006). „Antiproliferative and cytotoxic properties of bevacizumab on different ocular cells”. Br J Ophthalmol. 90 (10): 1316—21. PMC 1857456 . PMID 16723358. doi:10.1136/bjo.2006.095190..
- MANZANO, ROBERTA P. A.; PEYMAN, GHOLAM A.; KHAN, PALWASHA; KIVILCIM, MUHAMET (2006). „TESTING INTRAVITREAL TOXICITY OF BEVACIZUMAB (AVASTIN)”. Retina. 26 (3): 257—261. ISSN 0275-004X. doi:10.1097/00006982-200603000-00001.
- DAVIDORF, FREDERICK H.; MOUSER, J GARRET; DERICK, ROBERT J. (2006). „RAPID IMPROVEMENT OF RUBEOSIS IRIDIS FROM A SINGLE BEVACIZUMAB (AVASTIN) INJECTION”. Retina. 26 (3): 354—356. ISSN 0275-004X. doi:10.1097/00006982-200603000-00017.
- Brown, David M.; Michels, Mark; Kaiser, Peter K.; Heier, Jeffrey S.; Sy, Judy P.; Ianchulev, Tsontcho; Anchor Study, Group (2009). „Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study”. Ophthalmology. 116 (1): 57—65. PMID 19118696. doi:10.1016/j.ophtha.2008.10.018.
- Los, M.; Roodhart, J. M.; Voest, E. E. (април 2007). „Target practice: lessons from phase III trials with bevacizumab and vatalanib in the treatment of advanced colorectal cancer”. The Oncologist. 12 (4): 443—50. PMID 17470687. doi:10.1634/theoncologist.12-4-443.
- Rosenfeld, P. J.; Brown, D. M.; Heier, J. S.; Boyer, D. S.; Kaiser, P. K.; Chung, C. Y.; Kim, R. Y.; MARINA Study Group (2006). „Ranibizumab for neovascular age-related macular degeneration”. New England Journal of Medicine. 355 (14): 1419—1431. PMID 17021318. doi:10.1056/NEJMoa054481..
- Brown, D. M.; Kaiser, P. K.; Michels, M.; Soubrane, G.; Heier, J. S.; Kim, R. Y.; Sy, J. P.; Schneider, S.; ANCHOR Study Group (2006). „Ranibizumab versus verteporfin for neovascular age-related macular degeneration”. New England Journal of Medicine. 355 (14): 1432—1444. PMID 17021319. doi:10.1056/NEJMoa062655..
- Heier, J. S.; Brown, D. M.; Chong, V.; Korobelnik, J. F.; Kaiser, P. K.; Nguyen, Q. D.; Kirchhof, B.; Ho, A.; Ogura, Y.; Yancopoulos, G. D.; Stahl, N.; Vitti, R.; Berliner, A. J.; Soo, Y.; Anderesi, M.; Groetzbach, G.; Sommerauer, B.; Sandbrink, R.; Simader, C.; Schmidt-Erfurth, U.; VIEW 1 and VIEW 2 Study Groups (2012). „Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration”. Ophthalmology. 119 (12): 2537—2548. PMID 23084240. doi:10.1016/j.ophtha.2012.09.006.
- CATT Research Group; Martin, D. F.; Maguire, M. G.; Ying, G. S.; Grunwald, J. E.; Fine, S. L.; Jaffe, G. J. (2011). „Ranibizumab and bevacizumab for neovascular age-related macular degeneration”. New England Journal of Medicine. 364 (20): 1897—1908. PMC 3157322 . PMID 21526923. doi:10.1056/NEJMoa1102673..
- Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group; Martin, D. F.; Maguire, M. G.; Fine, S. L.; Ying, G. S.; Jaffe, G. J.; Grunwald, J. E.; Toth, C.; Redford, M.; Ferris Fl, 3rd (2012). „Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: Two-year results”. Ophthalmology. 119 (7): 1388—1398. PMC 3389193 . PMID 22555112. doi:10.1016/j.ophtha.2012.03.053..
- Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group; Maguire, M. G.; Martin, D. F.; Ying, G. S.; Jaffe, G. J.; Daniel, E.; Grunwald, J. E.; Toth, C. A.; Ferris Fl, 3rd; Fine, S. L. (2016). „Five-Year Outcomes with Anti-Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials”. Ophthalmology. 123 (8): 1751—1761. PMC 4958614 . PMID 27156698. doi:10.1016/j.ophtha.2016.03.045..
dx.doi.org
- Kaiser, Peter K. (2006). „Antivascular Endothelial Growth Factor Agents and Their Development: Therapeutic Implications in Ocular Diseases”. American Journal of Ophthalmology. 142 (4): 660—668.e1. ISSN 0002-9394. doi:10.1016/j.ajo.2006.05.061.
- Fernando, Himesh; Reszka, Anthony P.; Huppert, Julian; Ladame, Sylvain; Rankin, Sarah; Venkitaraman, Ashok R.; Neidle, Stephen; Balasubramanian, Shankar (2006-05-28). „A Conserved Quadruplex Motif Located in a Transcription Activation Site of the Human c-kit Oncogene”. Biochemistry. 45 (25): 7854—7860. ISSN 0006-2960. PMC 2195898 . PMID 16784237. doi:10.1021/bi0601510.
- Rosenfeld, Philip J.; Brown, David M.; Heier, Jeffrey S.; Boyer, David S.; Kaiser, Peter K.; Chung, Carol Y.; Kim, Robert Y. (2006-10-05). „Ranibizumab for Neovascular Age-Related Macular Degeneration”. New England Journal of Medicine. 355 (14): 1419—1431. ISSN 0028-4793. doi:10.1056/nejmoa054481.
- Rosenfeld, Philip J. (2006). „Intravitreal Avastin: The Low Cost Alternative to Lucentis?”. American Journal of Ophthalmology. 142 (1): 141—143. ISSN 0002-9394. PMID 16815262. doi:10.1016/j.ajo.2006.03.036.
- Avery, Robert L.; Pieramici, Dante J.; Rabena, Melvin D.; Castellarin, Alessandro A.; Nasir, Ma’an A.; Giust, Matthew J. (2006). „Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration”. Ophthalmology. 113 (3): 363—372.e5. ISSN 0161-6420. PMID 16458968. doi:10.1016/j.ophtha.2005.11.019.
- Bashshur, Ziad F.; Bazarbachi, Ali; Schakal, Alexandre; Haddad, Zeina A.; El Haibi, Christelle P.; Noureddin, Baha’ N. (2006). „Intravitreal Bevacizumab for the Management of Choroidal Neovascularization in Age-related Macular Degeneration”. American Journal of Ophthalmology. 142 (1): 1—9. ISSN 0002-9394. PMID 16815245. doi:10.1016/j.ajo.2006.02.037.
- Rudd, P; Siegler, M; Byyny, R L (1978). „Perioperative diabetic consultation”. Academic Medicine. 53 (7): 590—6. ISSN 1040-2446. doi:10.1097/00001888-197807000-00007.
- MANZANO, ROBERTA P. A.; PEYMAN, GHOLAM A.; KHAN, PALWASHA; KIVILCIM, MUHAMET (2006). „TESTING INTRAVITREAL TOXICITY OF BEVACIZUMAB (AVASTIN)”. Retina. 26 (3): 257—261. ISSN 0275-004X. doi:10.1097/00006982-200603000-00001.
- DAVIDORF, FREDERICK H.; MOUSER, J GARRET; DERICK, ROBERT J. (2006). „RAPID IMPROVEMENT OF RUBEOSIS IRIDIS FROM A SINGLE BEVACIZUMAB (AVASTIN) INJECTION”. Retina. 26 (3): 354—356. ISSN 0275-004X. doi:10.1097/00006982-200603000-00017.
nih.gov
ncbi.nlm.nih.gov
- Daekyu Sun; et al. (2005). „Facilitation of a structural transition in the polypurine/polypyrimidine tract within the proximal promoter region of the human VEGF gene by the presence of potassium and G-quadruplex-interactive agents”. Nucleic Acids Research. 33 (18): 6070—6080. PMC 1266068 . PMID 16239639. doi:10.1093/nar/gki917.
- Daekyu Sun; et al. (2008). „The proximal promoter region of the human vascular endothelial growth factor gene has a G-quadruplex structure that can be targeted by G-quadruplex–interactive agents”. Mol Cancer Ther April. 2008 (7): 880—889. PMC 2367258 . PMID 18413801. doi:10.1158/1535-7163.MCT-07-2119.
- Fernando, Himesh; Reszka, Anthony P.; Huppert, Julian; Ladame, Sylvain; Rankin, Sarah; Venkitaraman, Ashok R.; Neidle, Stephen; Balasubramanian, Shankar (2006-05-28). „A Conserved Quadruplex Motif Located in a Transcription Activation Site of the Human c-kit Oncogene”. Biochemistry. 45 (25): 7854—7860. ISSN 0006-2960. PMC 2195898 . PMID 16784237. doi:10.1021/bi0601510.
- Holmes K, Roberts OL, Thomas AM, Cross MJ (2007). „Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition.”. Cell Signal. 19 (10): 2003—2012. PMID 17658244. doi:10.1016/j.cellsig.2007.05.013.
- Stuttfeld, E.; Ballmer-Hofer K (2009). „Structure and function of VEGF receptors”. IUBMB Life. 61 (9): 915—22. PMID 19658168. S2CID 10190107. doi:10.1002/iub.234.
- Fujita, Nobuyuki; Imai, Jun-Ichi; Suzuki, Toru; Yamada, Masayuki; Ninomiya, Ken; Miyamoto, Kana; Iwasaki, Ryotaro; Morioka, Hideo; Matsumoto, Morio; Chiba, Kazuhiro; Watanabe, Shinya; Suda, Toshio; Toyama, Yoshiaki; Miyamoto, Takeshi (2008). „Vascular endothelial growth factor-A is a survival factor for nucleus pulposus cells in the intervertebral disc”. Biochemical and Biophysical Research Communications. 372 (2): 367—372. PMID 18492486. doi:10.1016/j.bbrc.2008.05.044.
- Gaudreault, J.; Fei, D.; Beyer, J. C.; Ryan, A.; Rangell, L.; Shiu, V.; Damico, L. A. (2007). „Pharmacokinetics and retinal distribution of ranibizumab, a humanized antibody fragment directed against VEGF-A, following intravitreal administration in rabbits”. Retina (Philadelphia, Pa.). 27 (9): 1260—6. PMID 18046235. S2CID 9336230. doi:10.1097/IAE.0b013e318134eecd.
- Gaudreault, J.; Fei, D.; Rusit, J.; Suboc, P.; Shiu, V. (2005). „Preclinical pharmacokinetics of Ranibizumab (RhuFabV2) after a single intravitreal administration”. Investigative Ophthalmology & Visual Science. 46 (2): 726—33. PMID 15671306. doi:10.1167/iovs.04-0601.
- Gaudreault, J.; Fei, D.; Beyer, J. C.; Ryan, A.; Rangell, L.; Shiu, V.; Damico, L. A. (2007). „Pharmacokinetics and retinal distribution of ranibizumab, a humanized antibody fragment directed against VEGF-A, following intravitreal administration in rabbits”. Retina (Philadelphia, Pa.). 27 (9): 1260—6. PMID 18046235. S2CID 9336230. doi:10.1097/IAE.0b013e318134eecd.
- Bakri, S. J.; Snyder, M. R.; Reid, J. M.; Pulido, J. S.; Ezzat, M. K.; Singh, R. J. (2007). „Pharmacokinetics of intravitreal ranibizumab (Lucentis)”. Ophthalmology. 114 (12): 2179—82. PMID 18054637. doi:10.1016/j.ophtha.2007.09.012.
- Kourlas, H.; Abrams, P. (2007). „Ranibizumab for the treatment of neovascular age-related macular degeneration: A review”. Clinical Therapeutics. 29 (9): 1850—61. PMID 18035187. doi:10.1016/j.clinthera.2007.09.008.
- Knox, Craig; Law, Vivian; Jewison, Timothy; Liu, Philip; Ly, Son; Frolkis, Alex; Pon, Allison; Banco, Kelly; Mak, Christine (2011). „DrugBank 3.0: a comprehensive resource for 'omics' research on drugs”. Nucleic Acids Research. 39 (Database issue): D1035—1041. ISSN 1362-4962. PMC 3013709 . PMID 21059682. doi:10.1093/nar/gkq1126.
- Wishart, David S.; Knox, Craig; Guo, An Chi; Cheng, Dean; Shrivastava, Savita; Tzur, Dan; Gautam, Bijaya; Hassanali, Murtaza (2008). „DrugBank: a knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Research. 36 (Database issue): D901—906. ISSN 1362-4962. PMC 2238889 . PMID 18048412. doi:10.1093/nar/gkm958.
- Gragoudas, E. S.; Adamis, A. P.; Cunningham Jr, E. T.; Feinsod, M.; Guyer, D. R.; VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group (2004). „Pegaptanib for neovascular age-related macular degeneration”. New England Journal of Medicine. 351 (27): 2805—16. PMID 15625332. S2CID 10050130. doi:10.1056/NEJMoa042760.
- Brown, D. M.; Kaiser, P. K.; Michels, M.; Soubrane, G.; Heier, J. S.; Kim, R. Y.; Sy, J. P.; Schneider, S.; ANCHOR Study Group (2006). „Ranibizumab versus verteporfin for neovascular age-related macular degeneration”. New England Journal of Medicine. 355 (14): 1432—44. PMID 17021319. doi:10.1056/NEJMoa062655.
- Rosenfeld, Philip J. (2006). „Intravitreal Avastin: The Low Cost Alternative to Lucentis?”. American Journal of Ophthalmology. 142 (1): 141—143. ISSN 0002-9394. PMID 16815262. doi:10.1016/j.ajo.2006.03.036.
- Stone, E. M. (2006). „A very effective treatment for neovascular macular degeneration”. New England Journal of Medicine. 355 (14): 1493—95. PMID 17021326. doi:10.1056/NEJMe068191..
- Avery, Robert L.; Pieramici, Dante J.; Rabena, Melvin D.; Castellarin, Alessandro A.; Nasir, Ma’an A.; Giust, Matthew J. (2006). „Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration”. Ophthalmology. 113 (3): 363—372.e5. ISSN 0161-6420. PMID 16458968. doi:10.1016/j.ophtha.2005.11.019.
- Bashshur, Ziad F.; Bazarbachi, Ali; Schakal, Alexandre; Haddad, Zeina A.; El Haibi, Christelle P.; Noureddin, Baha’ N. (2006). „Intravitreal Bevacizumab for the Management of Choroidal Neovascularization in Age-related Macular Degeneration”. American Journal of Ophthalmology. 142 (1): 1—9. ISSN 0002-9394. PMID 16815245. doi:10.1016/j.ajo.2006.02.037.
- Meyer C.H., Mennel S., Schmidt J.C., Kroll P.: Acute retinal pigment epithelial tear following intravitreal bevaciyumab (Avastin) injection for occult choroidal neovascularization secondary to age-related macular degeneration. Meyer, C. H.; Mennel, S.; Schmidt, J. C.; Kroll, P. (2006). „Acute retinal pigment epithelial tear following intravitreal bevacizumab (Avastin) injection for occult choroidal neovascularisation secondary to age related macular degeneration”. Br J Ophthalmol. 90 (9): 1207—08. PMC 1857397 . PMID 16929069. doi:10.1136/bjo.2006.093732..
- Luthra, S.; Narayanan, R.; Marques, L. E.; Chwa, M.; Kim, D. W.; Dong, J.; Seigel, G. M.; Neekhra, A.; Gramajo, A. L.; Brown, D. J.; Kenney, M. C.; Kuppermann, B. D. (2006). „Evaluation of in vitro effects of bevacizumab (Avastin) on retinal pigment epithelial, neurosensory retinal, and microvascular endothelial cells”. Retina. 26 (5): 512—18. PMID 16770256. S2CID 20956318. doi:10.1097/01.iae.0000222547.35820.52..
- Spitzer, M. S.; Wallenfels-Thilo, B.; Sierra, A.; Yoeruek, E.; Peters, S.; Henke-Fahle, S.; Bartz-Schmidt, K. U.; Szurman, P.; Tuebingen Bevacizumab Study Group (2006). „Antiproliferative and cytotoxic properties of bevacizumab on different ocular cells”. Br J Ophthalmol. 90 (10): 1316—21. PMC 1857456 . PMID 16723358. doi:10.1136/bjo.2006.095190..
- Brown, David M.; Michels, Mark; Kaiser, Peter K.; Heier, Jeffrey S.; Sy, Judy P.; Ianchulev, Tsontcho; Anchor Study, Group (2009). „Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study”. Ophthalmology. 116 (1): 57—65. PMID 19118696. doi:10.1016/j.ophtha.2008.10.018.
- Los, M.; Roodhart, J. M.; Voest, E. E. (април 2007). „Target practice: lessons from phase III trials with bevacizumab and vatalanib in the treatment of advanced colorectal cancer”. The Oncologist. 12 (4): 443—50. PMID 17470687. doi:10.1634/theoncologist.12-4-443.
- Rosenfeld, P. J.; Brown, D. M.; Heier, J. S.; Boyer, D. S.; Kaiser, P. K.; Chung, C. Y.; Kim, R. Y.; MARINA Study Group (2006). „Ranibizumab for neovascular age-related macular degeneration”. New England Journal of Medicine. 355 (14): 1419—1431. PMID 17021318. doi:10.1056/NEJMoa054481..
- Brown, D. M.; Kaiser, P. K.; Michels, M.; Soubrane, G.; Heier, J. S.; Kim, R. Y.; Sy, J. P.; Schneider, S.; ANCHOR Study Group (2006). „Ranibizumab versus verteporfin for neovascular age-related macular degeneration”. New England Journal of Medicine. 355 (14): 1432—1444. PMID 17021319. doi:10.1056/NEJMoa062655..
- Heier, J. S.; Brown, D. M.; Chong, V.; Korobelnik, J. F.; Kaiser, P. K.; Nguyen, Q. D.; Kirchhof, B.; Ho, A.; Ogura, Y.; Yancopoulos, G. D.; Stahl, N.; Vitti, R.; Berliner, A. J.; Soo, Y.; Anderesi, M.; Groetzbach, G.; Sommerauer, B.; Sandbrink, R.; Simader, C.; Schmidt-Erfurth, U.; VIEW 1 and VIEW 2 Study Groups (2012). „Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration”. Ophthalmology. 119 (12): 2537—2548. PMID 23084240. doi:10.1016/j.ophtha.2012.09.006.
- CATT Research Group; Martin, D. F.; Maguire, M. G.; Ying, G. S.; Grunwald, J. E.; Fine, S. L.; Jaffe, G. J. (2011). „Ranibizumab and bevacizumab for neovascular age-related macular degeneration”. New England Journal of Medicine. 364 (20): 1897—1908. PMC 3157322 . PMID 21526923. doi:10.1056/NEJMoa1102673..
- Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group; Martin, D. F.; Maguire, M. G.; Fine, S. L.; Ying, G. S.; Jaffe, G. J.; Grunwald, J. E.; Toth, C.; Redford, M.; Ferris Fl, 3rd (2012). „Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: Two-year results”. Ophthalmology. 119 (7): 1388—1398. PMC 3389193 . PMID 22555112. doi:10.1016/j.ophtha.2012.03.053..
- Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group; Maguire, M. G.; Martin, D. F.; Ying, G. S.; Jaffe, G. J.; Daniel, E.; Grunwald, J. E.; Toth, C. A.; Ferris Fl, 3rd; Fine, S. L. (2016). „Five-Year Outcomes with Anti-Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials”. Ophthalmology. 123 (8): 1751—1761. PMC 4958614 . PMID 27156698. doi:10.1016/j.ophtha.2016.03.045..
oxfordjournals.org
nar.oxfordjournals.org
- Daekyu Sun; et al. (2005). „Facilitation of a structural transition in the polypurine/polypyrimidine tract within the proximal promoter region of the human VEGF gene by the presence of potassium and G-quadruplex-interactive agents”. Nucleic Acids Research. 33 (18): 6070—6080. PMC 1266068 . PMID 16239639. doi:10.1093/nar/gki917.
semanticscholar.org
api.semanticscholar.org
- Stuttfeld, E.; Ballmer-Hofer K (2009). „Structure and function of VEGF receptors”. IUBMB Life. 61 (9): 915—22. PMID 19658168. S2CID 10190107. doi:10.1002/iub.234.
- Gaudreault, J.; Fei, D.; Beyer, J. C.; Ryan, A.; Rangell, L.; Shiu, V.; Damico, L. A. (2007). „Pharmacokinetics and retinal distribution of ranibizumab, a humanized antibody fragment directed against VEGF-A, following intravitreal administration in rabbits”. Retina (Philadelphia, Pa.). 27 (9): 1260—6. PMID 18046235. S2CID 9336230. doi:10.1097/IAE.0b013e318134eecd.
- Gaudreault, J.; Fei, D.; Beyer, J. C.; Ryan, A.; Rangell, L.; Shiu, V.; Damico, L. A. (2007). „Pharmacokinetics and retinal distribution of ranibizumab, a humanized antibody fragment directed against VEGF-A, following intravitreal administration in rabbits”. Retina (Philadelphia, Pa.). 27 (9): 1260—6. PMID 18046235. S2CID 9336230. doi:10.1097/IAE.0b013e318134eecd.
- Gragoudas, E. S.; Adamis, A. P.; Cunningham Jr, E. T.; Feinsod, M.; Guyer, D. R.; VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group (2004). „Pegaptanib for neovascular age-related macular degeneration”. New England Journal of Medicine. 351 (27): 2805—16. PMID 15625332. S2CID 10050130. doi:10.1056/NEJMoa042760.
- Luthra, S.; Narayanan, R.; Marques, L. E.; Chwa, M.; Kim, D. W.; Dong, J.; Seigel, G. M.; Neekhra, A.; Gramajo, A. L.; Brown, D. J.; Kenney, M. C.; Kuppermann, B. D. (2006). „Evaluation of in vitro effects of bevacizumab (Avastin) on retinal pigment epithelial, neurosensory retinal, and microvascular endothelial cells”. Retina. 26 (5): 512—18. PMID 16770256. S2CID 20956318. doi:10.1097/01.iae.0000222547.35820.52..
web.archive.org
- IGMT Link:http://imgt.cines.fr/3Dstructure-DB/cgi/details.cgi?pdbcode=1CZ8&Part=Chain Архивирано на сајту Wayback Machine (7. децембар 2008)
worldcat.org
- Kaiser, Peter K. (2006). „Antivascular Endothelial Growth Factor Agents and Their Development: Therapeutic Implications in Ocular Diseases”. American Journal of Ophthalmology. 142 (4): 660—668.e1. ISSN 0002-9394. doi:10.1016/j.ajo.2006.05.061.
- Fernando, Himesh; Reszka, Anthony P.; Huppert, Julian; Ladame, Sylvain; Rankin, Sarah; Venkitaraman, Ashok R.; Neidle, Stephen; Balasubramanian, Shankar (2006-05-28). „A Conserved Quadruplex Motif Located in a Transcription Activation Site of the Human c-kit Oncogene”. Biochemistry. 45 (25): 7854—7860. ISSN 0006-2960. PMC 2195898 . PMID 16784237. doi:10.1021/bi0601510.
- Knox, Craig; Law, Vivian; Jewison, Timothy; Liu, Philip; Ly, Son; Frolkis, Alex; Pon, Allison; Banco, Kelly; Mak, Christine (2011). „DrugBank 3.0: a comprehensive resource for 'omics' research on drugs”. Nucleic Acids Research. 39 (Database issue): D1035—1041. ISSN 1362-4962. PMC 3013709 . PMID 21059682. doi:10.1093/nar/gkq1126.
- Wishart, David S.; Knox, Craig; Guo, An Chi; Cheng, Dean; Shrivastava, Savita; Tzur, Dan; Gautam, Bijaya; Hassanali, Murtaza (2008). „DrugBank: a knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Research. 36 (Database issue): D901—906. ISSN 1362-4962. PMC 2238889 . PMID 18048412. doi:10.1093/nar/gkm958.
- Rosenfeld, Philip J.; Brown, David M.; Heier, Jeffrey S.; Boyer, David S.; Kaiser, Peter K.; Chung, Carol Y.; Kim, Robert Y. (2006-10-05). „Ranibizumab for Neovascular Age-Related Macular Degeneration”. New England Journal of Medicine. 355 (14): 1419—1431. ISSN 0028-4793. doi:10.1056/nejmoa054481.
- Rosenfeld, Philip J. (2006). „Intravitreal Avastin: The Low Cost Alternative to Lucentis?”. American Journal of Ophthalmology. 142 (1): 141—143. ISSN 0002-9394. PMID 16815262. doi:10.1016/j.ajo.2006.03.036.
- Avery, Robert L.; Pieramici, Dante J.; Rabena, Melvin D.; Castellarin, Alessandro A.; Nasir, Ma’an A.; Giust, Matthew J. (2006). „Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration”. Ophthalmology. 113 (3): 363—372.e5. ISSN 0161-6420. PMID 16458968. doi:10.1016/j.ophtha.2005.11.019.
- Bashshur, Ziad F.; Bazarbachi, Ali; Schakal, Alexandre; Haddad, Zeina A.; El Haibi, Christelle P.; Noureddin, Baha’ N. (2006). „Intravitreal Bevacizumab for the Management of Choroidal Neovascularization in Age-related Macular Degeneration”. American Journal of Ophthalmology. 142 (1): 1—9. ISSN 0002-9394. PMID 16815245. doi:10.1016/j.ajo.2006.02.037.
- Rudd, P; Siegler, M; Byyny, R L (1978). „Perioperative diabetic consultation”. Academic Medicine. 53 (7): 590—6. ISSN 1040-2446. doi:10.1097/00001888-197807000-00007.
- MANZANO, ROBERTA P. A.; PEYMAN, GHOLAM A.; KHAN, PALWASHA; KIVILCIM, MUHAMET (2006). „TESTING INTRAVITREAL TOXICITY OF BEVACIZUMAB (AVASTIN)”. Retina. 26 (3): 257—261. ISSN 0275-004X. doi:10.1097/00006982-200603000-00001.
- DAVIDORF, FREDERICK H.; MOUSER, J GARRET; DERICK, ROBERT J. (2006). „RAPID IMPROVEMENT OF RUBEOSIS IRIDIS FROM A SINGLE BEVACIZUMAB (AVASTIN) INJECTION”. Retina. 26 (3): 354—356. ISSN 0275-004X. doi:10.1097/00006982-200603000-00017.